BHUBANESWAR - A three-member central team Friday arrived in Orissa for an assessment of the situation after an outbreak of cholera and other water-borne diseases has claimed at least 40 lives in the state's Rayagada district since August.

more images

Several medical associations and U.S federal experts have come to the conclusion that PSA (Prostate-specific antigen) tests do not improve the number of prostate cancer survivals. Routine PSA screening tests should be skipped as it is found ineffective in decreasing the mortality rate of men affected by prostate cancer. The screening that starts from an early age of 40 in men is beneficial for some but most men are loosers. As the early regular screening results in over-diagnosis of prostate cancer leading to unnecessary anxiety among men. Prostate cancer is typically a slow growing cancer and so many many doctors are suggesting that if a man in his 70s is detected with this cancer, the man will die due to some other reason before the cancer progresses. Another justification to the fact that PSA testing is not required to be started in young men in a routine basis is that too many men will have to be tested and diagnosed to find one affected patient. This slow growing cancer will lead to over-treatment in the form of surgeries and radiations.